Cargando…

Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening

Evaluating the performance of serum prostate-specific antigen (PSA) test in population-based screening with receiver operating characteristics (ROC) curve often neglects the time dimension. Asymptomatic cases with negative PSA test would have been missed if sojourn time is not taken into account to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jen, Hsiao-Hsuan, Chang, Wei-Jung, Hsu, Chen-Yang, Yen, Amy Ming-Fang, Auvinen, Anssi, Chen, Tony Hsiu-Hsi, Chen, Sam Li-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691355/ https://www.ncbi.nlm.nih.gov/pubmed/33244038 http://dx.doi.org/10.1038/s41598-020-77668-w

Ejemplares similares

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
por: Pashayan, N, et al.
Publicado: (2009)

ROC Solid: Receiver Operator Characteristic (ROC) Curves as a Foundation for Better Diagnostic Tests
por: Junge, Mark R. J., et al.
Publicado: (2018)

Receiver Operating Characteristic (ROC) Curve: Practical Review for Radiologists
por: Park, Seong Ho, et al.
Publicado: (2004)

Roc curves for continuous data
por: Krzanowski, Wojtek J, et al.
Publicado: (2009)

Gene‒Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer
por: Yang, Teng-Kai, et al.
Publicado: (2019)

Biomarker selection for medical diagnosis using the partial area under the ROC curve
por: Hsu, Man-Jen, et al.
Publicado: (2014)

pROC: an open-source package for R and S+ to analyze and compare ROC curves
por: Robin, Xavier, et al.
Publicado: (2011)

Prostate cancer screening: what can we learn from randomised trials?
por: Auvinen, Anssi
Publicado: (2018)

Assessing Interactions of Two Loci (rs4242382 and rs10486567) in Familial Prostate Cancer: Statistical Evaluation of Epistasis
por: Chen, Li-Sheng, et al.
Publicado: (2014)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

Use of ROC curves in clinical and experimental studies
por: Polo, Tatiana Cristina Figueira, et al.
Publicado: (2020)

A pre-symptomatic incubation model for precision strategies of screening, quarantine, and isolation based on imported COVID-19 cases in Taiwan
por: Jen, Grace Hsiao-Hsuan, et al.
Publicado: (2022)

Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia
por: Hsiao, Chun-Jen, et al.
Publicado: (2016)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Model-Based ROC Curve: Examining the Effect of Case Mix and Model Calibration on the ROC Plot
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

ROC curve analyses of eyewitness identification decisions: An analysis of the recent debate
por: Rotello, Caren M., et al.
Publicado: (2016)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
por: Cho, Hyungseok, et al.
Publicado: (2022)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

A note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening
por: Draisma, Gerrit, et al.
Publicado: (2013)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Application of Receiver Operating Characteristic (ROC) Curves for Explosives Detection Using Different Sampling and Detection Techniques
por: Young, Mimy, et al.
Publicado: (2013)

Receiver operating characteristic (ROC) curve for classification of (18)F-NaF uptake on PET/CT
por: Valadares, Agnes Araujo, et al.
Publicado: (2016)

Smooth ROC curve estimation via Bernstein polynomials
por: Wang, Dongliang, et al.
Publicado: (2021)

Exact Probability Distribution for the ROC Area under Curve
por: Ekström, Joakim, et al.
Publicado: (2023)

Application of the skew exponential power distribution to ROC curves
por: Attwood, Kristopher, et al.
Publicado: (2022)

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
por: Koo, Jin Mo, et al.
Publicado: (2010)

Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer
por: Chavan, Sushant V., et al.
Publicado: (2014)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013)

The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
por: Flores-Fraile, María-Carmen, et al.
Publicado: (2020)

Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men
por: Coric, Jozo, et al.
Publicado: (2015)

Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
por: Azab, Sherif, et al.
Publicado: (2012)

Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
por: Filella, Xavier, et al.
Publicado: (2016)

PROSTATE-SPECIFIC ANTIGEN (PSA) VALUES IN PATIENTS WITH LOW- AND HIGH-RISK PROSTATIC ADENOCARCINOMA
por: Mašić, Silvija, et al.
Publicado: (2019)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening
por: Jen, Grace Hsiao-Hsuan, et al.
Publicado: (2021)

Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
por: Li, Qing Kay, et al.
Publicado: (2015)

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients
por: Merriel, Samuel W. D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g44f2ngch9vao2q2cs4ndaiv0i